Yosemite Fund II
Yosemite
◆ Fund Size
$200M
◆ Check Size
◆ Location
United States
◆ Activity
Statusactively investing
◆ Links
◆ Investment Thesis
Oncology-focused venture firm building biotech companies from scratch out of early academic research using a mix of philanthropy and outside investment capital. Uses AI for drug discovery and clinical trial design.
◆ About Yosemite
Yosemite is a venture capital firm focused on investing in innovative solutions that address cancer, with a mission to transform the landscape of cancer treatment and care.
◆ Sectors
◆ Stages
◆ Geography Focus
◆ Team
| Name | Title | Role | Links |
|---|---|---|---|
| Anna Darbyshire | Chief Operating Officer | Senior | |
| Carrie Kibler | General Counsel | Senior | |
| Dan McHugh | Head of Investment Team | Senior | |
| Koki Kikukawa | Founder and Chief Executive Officer | Founder | |
| Reed Jobs | Founder and President | Founder |
◆ Notable Investments
◆ Traits
Leads rounds
Co-invests
◆ FAQ
What does Yosemite Fund II invest in?
Yosemite Fund II invests in Biotech, Drug Discovery, AI Infrastructure and Diagnostics at the pre-seed, seed, series-a and series-b stages.
Which geographies does Yosemite Fund II focus on?
Yosemite Fund II focuses on United States, and is headquartered in United States.
What is Yosemite Fund II's typical check size?
Yosemite Fund II typically writes checks of $1M to $10M.